Recently, METTL16 was reported to exert an m6A-independent role in hepatocellular carcinoma cells in vitro (Su et al, 2022), raising a question about whether METTL16 plays an m6A-dependent or m6A-independent role in the development of HSPCs in vivo. This evidence concerns the gene METTL16 and hepatocellular carcinoma.